# Imcivree

NDC: 72829-010
Generic name: setmelanotide
Labeler / Manufacturer: Rhythm Pharmaceuticals, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20201214

FDA application: NDA213793

## Active ingredients

- SETMELANOTIDE: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72829-010"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72829-010
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=70c3ccf7-4df0-4c75-ba07-fede9970c8d9